Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

ETB2 receptor subtype stimulation relaxes the iris sphincter muscle

A. Rocha-Sousa, J. Saraiva, M. Amaral, P. Alves-Faria, F. Falcao-Reis, A. F. Leite-Moreira

. 2009 ; 58 (6) : 835-842.

Jazyk angličtina Země Česko

Perzistentní odkaz   https://www.medvik.cz/link/bmc10012554

Effects of ETB receptor stimulation and its subcellular pathways were evaluated in carbachol pre-contracted rabbit iris sphincter muscles (n=51). ETB stimulation with sarafotoxin (SRTX-c; 10-10-10-6 M) was tested in the absence (n=7) or presence of 10-5 M of: BQ-788 (ETB2 receptor antagonist; n=6), L-NA (NOS inhibitor; n=7) or indomethacin (cyclooxygenase inhibitor; n=10). Effects of ETB stimulation by endothelin-1 (ET-1; 10-10– 10-7 M) in the presence of an ETA receptor antagonist (BQ-123; 10-5 M; n=7) and of ETB1 stimulation by IRL-1620 (10-10–10-7 M; n=7) were also tested. Finally, the effects of SRTX-c (10-9–10-7 M) in electric field stimulation (EFS) contraction were evaluated (n=7). ETB receptor stimulation by SRTX-c or ET-1 in presence of BQ-123 promoted a concentration-dependent relaxation of the rabbit iris sphincter muscle by 10.8±2.0 % and 9.4±1.8 %, respectively. This effect was blocked by BQ-788 (-2.3±2.0 %), L-NA (4.5±2.3 %) or indomethacin (2.3±2.9 %). Selective ETB1 stimulation by IRL-1620 did not relax the iris sphincter muscle (0.9±5.4 %). EFS elicited contraction was not altered by SRTX-c. In conclusion, ETB receptor stimulation relaxes the carbachol precontracted iris sphincter muscle, an effect that is mediated by the ETB2 receptor subtype, through NO and the release of prostaglandins.

Citace poskytuje Crossref.org

Bibliografie atd.

Lit.: 43

000      
00000naa 2200000 a 4500
001      
bmc10012554
003      
CZ-PrNML
005      
20111210163230.0
008      
100525s2009 xr e eng||
009      
AR
024    7_
$a 10.33549/physiolres.931365 $2 doi
040    __
$a ABA008 $b cze $c ABA008 $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xr
100    1_
$a Rocha-Sousa, A.
245    10
$a ETB2 receptor subtype stimulation relaxes the iris sphincter muscle / $c A. Rocha-Sousa, J. Saraiva, M. Amaral, P. Alves-Faria, F. Falcao-Reis, A. F. Leite-Moreira
314    __
$a Laboratory of Physiology, Faculty of Medicine, University of Porto, Porto
504    __
$a Lit.: 43
520    9_
$a Effects of ETB receptor stimulation and its subcellular pathways were evaluated in carbachol pre-contracted rabbit iris sphincter muscles (n=51). ETB stimulation with sarafotoxin (SRTX-c; 10-10-10-6 M) was tested in the absence (n=7) or presence of 10-5 M of: BQ-788 (ETB2 receptor antagonist; n=6), L-NA (NOS inhibitor; n=7) or indomethacin (cyclooxygenase inhibitor; n=10). Effects of ETB stimulation by endothelin-1 (ET-1; 10-10– 10-7 M) in the presence of an ETA receptor antagonist (BQ-123; 10-5 M; n=7) and of ETB1 stimulation by IRL-1620 (10-10–10-7 M; n=7) were also tested. Finally, the effects of SRTX-c (10-9–10-7 M) in electric field stimulation (EFS) contraction were evaluated (n=7). ETB receptor stimulation by SRTX-c or ET-1 in presence of BQ-123 promoted a concentration-dependent relaxation of the rabbit iris sphincter muscle by 10.8±2.0 % and 9.4±1.8 %, respectively. This effect was blocked by BQ-788 (-2.3±2.0 %), L-NA (4.5±2.3 %) or indomethacin (2.3±2.9 %). Selective ETB1 stimulation by IRL-1620 did not relax the iris sphincter muscle (0.9±5.4 %). EFS elicited contraction was not altered by SRTX-c. In conclusion, ETB receptor stimulation relaxes the carbachol precontracted iris sphincter muscle, an effect that is mediated by the ETB2 receptor subtype, through NO and the release of prostaglandins.
650    _2
$a financování organizované $7 D005381
650    _2
$a zvířata $7 D000818
650    _2
$a karbachol $x farmakologie $7 D002217
650    _2
$a vztah mezi dávkou a účinkem léčiva $7 D004305
650    _2
$a elektrická stimulace $7 D004558
650    _2
$a endotelin-1 $x metabolismus $7 D019332
650    _2
$a endoteliny $x farmakologie $7 D016232
650    _2
$a inhibitory enzymů $7 D004791
650    _2
$a indomethacin $x farmakologie $7 D007213
650    _2
$a iris $x metabolismus $x účinky léků $7 D007498
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a relaxace svalu $x účinky léků $7 D009126
650    _2
$a hladké svalstvo $x metabolismus $x účinky léků $7 D009130
650    _2
$a oxid dusnatý $x metabolismus $7 D009569
650    _2
$a synthasa oxidu dusnatého $x antagonisté a inhibitory $x metabolismus $7 D019001
650    _2
$a nitroarginin $x farmakologie $7 D019335
650    _2
$a oligopeptidy $x farmakologie $7 D009842
650    _2
$a peptidové fragmenty $x farmakologie $7 D010446
650    _2
$a peptidy $x farmakologie $7 D010455
650    _2
$a piperidiny $x farmakologie $7 D010880
650    _2
$a cyklooxygenasy $x metabolismus $7 D011451
650    _2
$a prostaglandiny $x metabolismus $7 D011453
650    _2
$a králíci $7 D011817
650    _2
$a receptor endotelinu A $x metabolismus $7 D044022
650    _2
$a receptor endotelinu B $x agonisté $x metabolismus $7 D044023
700    1_
$a Saraiva, J.
700    1_
$a Amaral, M. $7 gn_A_00005267
700    1_
$a Alves-Faria, P. $7 gn_A_00005164
700    1_
$a Falcao-Reis, F.
700    1_
$a Leite-Moreira, A. F.
773    0_
$w MED00003824 $t Physiological research $g Roč. 58, č. 6 (2009), s. 835-842 $x 0862-8408
856    41
$u http://www.biomed.cas.cz/physiolres/pdf/58/58_835.pdf $y plný text volně přístupný
910    __
$a ABA008 $b A 4120 $c 266 $y 8
990    __
$a 20100525095435 $b ABA008
991    __
$a 20100603111923 $b ABA008
999    __
$a ok $b bmc $g 726411 $s 589565
BAS    __
$a 3
BMC    __
$a 2009 $b 58 $c 6 $m Physiological research $x MED00003824 $d 835-842
LZP    __
$a 2010-28/ipme

Najít záznam

Citační ukazatele

Nahrávání dat ...